141 related articles for article (PubMed ID: 6531624)
1. [Correlation between circulating HBV-DNA, HBcAb titers and post-transfusional hepatitis B].
Bedarida G; Cambiè G; D'Agostino F
Riv Emoter Immunoematol; 1984; 31(1):88-100. PubMed ID: 6531624
[No Abstract] [Full Text] [Related]
2. Serological markers of hepatitis B infection.
Burrell CJ
Clin Gastroenterol; 1980 Jan; 9(1):47-63. PubMed ID: 6994952
[TBL] [Abstract][Full Text] [Related]
3. [Clinical significance of hepatitis B virus markers ].
Iino S
Nihon Naika Gakkai Zasshi; 1990 Aug; 79(8):992-6. PubMed ID: 2230488
[No Abstract] [Full Text] [Related]
4. Quantification of hepatitis B virus DNA over a wide range from serum for studying viral replicative activity in response to treatment and in recurrent infection.
Ranki M; Schätzl HM; Zachoval R; Uusi-Oukari M; Lehtovaara P
Hepatology; 1995 Jun; 21(6):1492-9. PubMed ID: 7768492
[TBL] [Abstract][Full Text] [Related]
5. Occult hepatitis B virus infection.
Allain JP
Transfus Clin Biol; 2004 Feb; 11(1):18-25. PubMed ID: 14980545
[TBL] [Abstract][Full Text] [Related]
6. Lack of correlation between HBsAg and HBV DNA levels in blood donors who test positive for HBsAg and anti-HBc: implications for future HBV screening policy.
Kuhns MC; Kleinman SH; McNamara AL; Rawal B; Glynn S; Busch MP;
Transfusion; 2004 Sep; 44(9):1332-9. PubMed ID: 15318857
[TBL] [Abstract][Full Text] [Related]
7. [Clinical aspects and diagnosis of chronic viral hepatitis B].
Grigor'ev PIa; Iakovenko EP; Zakharov VN; Saiapina ES; Shubina GI
Klin Med (Mosk); 1984 Feb; 62(2):5-10. PubMed ID: 6708442
[No Abstract] [Full Text] [Related]
8. HBV markers (HBsAg, HBSAb, HBCAb in 160 medical students at Kenyatta National Hospital.
Lule GN; Okoth F; Ogutu EO; Mwai SJ
East Afr Med J; 1989 May; 66(5):315-8. PubMed ID: 2791927
[TBL] [Abstract][Full Text] [Related]
9. [Role of hepatitis B virus in the etiology of serologically silent viral hepatitis].
Emile JF
Gastroenterol Clin Biol; 1995 Oct; 19(10):856-7. PubMed ID: 8566575
[No Abstract] [Full Text] [Related]
10. Posttransfusion hepatitis B infection after revised screening for hepatitis B.
Arai M; Koshihara K; Takahashi Y; Fukutake K
Int J Hematol; 1999 Jan; 69(1):61. PubMed ID: 10641447
[No Abstract] [Full Text] [Related]
11. Lack of correlation between hepatitis B surface antigen and hepatitis B virus DNA levels in blood donors.
Allain JP; Sarkodie F; Candotti D; Opare-Sem O
Transfusion; 2005 Jun; 45(6):1039-40. PubMed ID: 15935007
[No Abstract] [Full Text] [Related]
12. Hepatitis B virus DNA-positive, hepatitis B surface antigen-negative blood donations intercepted by anti-hepatitis B core antigen testing: the Canadian Blood Services experience.
O'Brien SF; Fearon MA; Yi QL; Fan W; Scalia V; Muntz IR; Vamvakas EC
Transfusion; 2007 Oct; 47(10):1809-15. PubMed ID: 17880605
[TBL] [Abstract][Full Text] [Related]
13. A revised method for estimating hepatitis B virus transfusion residual risk based on antibody to hepatitis B core antigen incident cases.
Laperche S; Maniez M; Barlet V; El Ghouzzi MH; Le Vacon F; Levayer T; Lunel F; Morel P; Mouillot L; Piquet Y; Pillonel J;
Transfusion; 2008 Nov; 48(11):2308-14. PubMed ID: 18673347
[TBL] [Abstract][Full Text] [Related]
14. What you need to know: interpreting hepatitis B viral markers.
Tan CK
Singapore Med J; 1998 Mar; 39(3):139-40. PubMed ID: 9632977
[No Abstract] [Full Text] [Related]
15. Current status of posttransfusion hepatitis.
Alter HJ; Holland PV; Purcell RH
Pathobiol Annu; 1980; 10():135-56. PubMed ID: 6777742
[No Abstract] [Full Text] [Related]
16. The prevalence of occult hepatitis B virus infection in type 2 diabetes mellitus patients.
Demir M; Serin E; Göktürk S; Ozturk NA; Kulaksizoglu S; Ylmaz U
Eur J Gastroenterol Hepatol; 2008 Jul; 20(7):668-73. PubMed ID: 18679070
[TBL] [Abstract][Full Text] [Related]
17. Infectivity of blood components with low hepatitis B virus DNA levels identified in a lookback program.
Satake M; Taira R; Yugi H; Hino S; Kanemitsu K; Ikeda H; Tadokoro K
Transfusion; 2007 Jul; 47(7):1197-205. PubMed ID: 17581154
[TBL] [Abstract][Full Text] [Related]
18. [Hepatitis B antigen components in liver tissue in correlation to specific blood parameters and forms of hepatitis].
Bianchi L; Gudat F
Verh Dtsch Ges Inn Med; 1976; 82 Pt 1():87-93. PubMed ID: 1029305
[No Abstract] [Full Text] [Related]
19. Full-length genomic analysis of hepatitis B virus isolates in a patient progressing from hepatitis to hepatocellular carcinoma.
Lin X; Qian GS; Lu PX; Wu L; Wen YM
J Med Virol; 2001 Jul; 64(3):299-304. PubMed ID: 11424118
[TBL] [Abstract][Full Text] [Related]
20. Performance of an algorithm for the reentry of volunteer blood donors deferred due to false-positive test results for antibody to hepatitis B core antigen.
Katz L; Strong DM; Tegtmeier G; Stramer S
Transfusion; 2008 Nov; 48(11):2315-22. PubMed ID: 18647367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
